PDF FDA recalls heart medication valsartan, citing cancer concerns
FDA recalls heart medication valsartan,
citing cancer concerns
17 July 2018, by Monique O. Madan, Miami Herald
The U.S. Food and Drug Administration issued a
Valsartan, Teva Pharmaceuticals Industries
voluntary recall of several medications that contain
Ltd.
the active ingredient valsartan, which is used to
Valsartan/Hydrochlorothiazide (HCTZ),
treat high blood pressure and heart failure.
Solco Healthcare.
Valsartan/Hydrochlorothiazide (HCTZ),
"This recall is due to an impurity, N-
Teva Pharmaceuticals Industries Ltd.
nitrosodimethylamine (NDMA), which was found in
the recalled products, the FDA said in a statement. ?2018 Miami Herald
"However, not all products containing valsartan are Distributed by Tribune Content Agency, LLC.
being recalled."
Officials say NDMA is classified as a probable human carcinogen--a substance that could cause cancer. They said that finding findings are based on results from recent laboratory tests.
The FDA said the carcinogen's presence is "thought to be related to changes in the way the active substance was manufactured."
"We have carefully assessed the valsartancontaining medications sold in the United States, and we've found that the valsartan sold by these specific companies does not meet our safety standards. This is why we've asked these companies to take immediate action to protect patients," said Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research.
Patients already taking the recalled medications should contact their pharmacist or doctor immediately, the FDA says.
To determine whether a specific product has been recalled, patients should look at the drug name and company name on the label of their prescription bottle. If the information is not on the bottle, patients should contact the pharmacy that dispensed the medicine.
The specific medicines recalled are:
Valsartan, Major Pharmaceuticals. Valsartan, Solco Healthcare.
1 / 2
APA citation: FDA recalls heart medication valsartan, citing cancer concerns (2018, July 17) retrieved 11 May 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
Powered by TCPDF ()
2 / 2
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- pdf your 2019 prescription drug list
- pdf resources for searching california laws and regulations
- pdf aurobindo pharma recall of valsartan containing products
- pdf news state of ohio board of pharmacy
- pdf fda recalls heart medication valsartan citing cancer concerns
- pdf a prescription for investing in health care prices and
- pdf montelukast tablets by camber pharmaceuticals recall due to
- pdf news kentucky board of pharmacy
- pdf news louisiana board of pharmacy
Related searches
- fda recalls blood pressure medication
- fda recalls blood pressure drugs
- fda blood pressure medication alert
- fda recalls hills dog food
- fda blood pressure medication recalled
- heart medication recall 2019
- heart medication beginning with e
- fda blood pressure medication recall list
- fda recalls blood pressure medication 2019
- fda recalls blood pressure meds
- heart medication and erectile dysfunction
- new heart medication 2018